Categories: Tech

Spirit Blockchain Capital Files Q3 2025 Financial Statements and Announces CFO Transition

 | Source: Spirit Blockchain Capital Inc.

Vancouver, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) — Spirit Blockchain Capital Inc. (CSE: SPIR) (“Spirit” or the “Company”) announces that it has filed its interim financial statements for the three and nine months ended September 30, 2025 (the “Financial Statements”) and the accompanying management’s discussion and analysis (the “MD&A”). The filings have been made in accordance with the continuous disclosure requirements of the Canadian Securities Exchange and applicable securities legislation. Copies of the Financial Statements and MD&A are available under the Company’s profile on www.sedarplus.ca and on the Company’s website at www.spiritblockchain.com.

The Company also announces the appointment of Lewis Bateman, the Chief Executive Officer of the Company, as Interim Chief Financial Officer of the Company following the departure of Inder Saini as Chief Financial Officer.  The Company continues to work on identifying a new Chief Financial Officer. 

About Spirit Blockchain Capital

Spirit Blockchain Capital Inc. (CSE: SPIR) is a Canadian public company focused on the development and operation of blockchain-based financial infrastructure, including tokenization platforms, payments enablement, and infrastructure support for regulated digital-asset products in Europe. Spirit’s objective is to generate recurring revenue from technology licensing, infrastructure support, and related digital-asset services. Spirit is not an investment company or investment fund. For more information, please visit: www.spiritblockchain.com.

On behalf of the Board of Directors

SPIRIT BLOCKCHAIN CAPITAL INC.

For media inquiries, please contact:

Lewis Bateman
Chief Executive Officer
info@spiritblockchain.com
(604) 757-0331

Forward-Looking Statements

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “may”, “will”, “project”, “should”, “believe”, “plans”, “intends” and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Factors that could materially affect such forward-looking information are described under the heading “Risk Factors” in the Company’s long form prospectus dated August 8, 2022, and other continuous disclosure documents that are available on the Company’s profile on SEDAR+ at www.sedarplus.ca. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available.

No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.

The Canadian Securities Exchange has not reviewed, approved, or disapproved the contents of this news release.

GlobeNews Wire

Recent Posts

BRIAN MAY AND STARMUS MARK 10 YEARS OF THE STEPHEN HAWKING SCIENCE MEDAL WITH THE LAUNCH OF THE JANE GOODALL EARTH MEDAL

LONDON, Dec. 19, 2025 /PRNewswire/ -- This week at London's Royal Society, board members of…

35 minutes ago

Psyence BioMed Announces Approval for Use of PsyLabs Psilocybin Product in Phase IIb Clinical Trial

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed”…

6 hours ago

ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories

Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and…

6 hours ago

Beenu Arora, CEO & Co-Founder of Cyble, Recognized by ET Edge as an Impactful CEO 2025

MUMBAI, India, Dec. 19, 2025 /PRNewswire/ -- ET Edge has recognized Beenu Arora, CEO &…

6 hours ago

Bybit launches in the UK to meet rising demand for digital-asset platforms

Bybit launches its UK platform, operating under a framework designed to meet FCA financial promotion…

6 hours ago